Long, M T <br/><br/>
Safety and efficacy of recombinant activated factor VII for refractory hemorrhage in pediatric patients on extracorporeal membrane oxygenation: a single center review.  [electronic resource] 

 -  Perfusion  Mar 2014 
 - 163-70 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1477-111X 
<br/><br/><label>Standard No.: </label>10.1177/0267659113499782  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Blood Component Transfusion<br/>Child, Preschool<br/>Extracorporeal Membrane Oxygenation--adverse effects<br/>Factor VIIa--administration & dosage<br/>Female<br/>Health Records, Personal<br/>Hemorrhage--etiology<br/>Humans<br/>Infant<br/>Male<br/>Recombinant Proteins--administration & dosage<br/>Retrospective Studies